BOPA’s mission is to promote excellence in the pharmaceutical care of patients with cancer. It works through education, communication, research and innovation, supporting its members with access to courses, forums, resources and events. Their free to access “Let’s Communicate Cancer” e-learning programme provides pharmacy staff with an understanding of the signs and symptoms of cancer, the lifestyle factors that influence the risk of developing cancer, cancer treatments and appropriate referrals for patients with suspected or confirmed malignancy. The programme is presented as bite-sized sections, with videos, animation, quizzes and slide shows. The e-learning will give the whole pharmacy team the knowledge and confidence to support cancer patients – from early diagnosis and through treatment.

Jackie Lewis, one of the creators of the Lets Communicate Cancer programme and Andy Walker, co-chair of the BOPA community pharmacy group commented: “We are thrilled that the Lets Communicate Cancer programme has received accreditation. BOPA is passionate about the role of the pharmacy profession to deliver excellent care to patients with cancer and are delighted that RSPH has joined us to support our vision. Community pharmacy has a huge potential to act as a resource for patients to access services and could support a range of initiatives, from earlier diagnosis to holistic advice around managing symptoms or the effects of treatment. The Lets Communicate Cancer programme provides community pharmacy teams with a valuable educational resource to support these developments and help the pharmacy profession deliver the best possible standard of care for patients.”

Janice Constable, RSPH Membership & Educational Services Director commented: “We are delighted that this programme has joined our range of RSPH accredited courses. This e-learning helps staff to understand the causes of cancer, common symptoms and the side effects of treatments. The advice provided by pharmacy staff is vital to help spot the early signs of cancer, encourage early referrals and manage the side effects of treatments. This is an important programme which will benefit all pharmacy staff.”

Financial support for the development of the course was provided by Pfizer Limited as a Medical and Educational Goods and Service.